Tirzepatide is an antidiabetic medication used to treat type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections. From Wikipedia
Schumer cites Mounjaro plus hormone therapy following a prior adverse reaction to Ozempic.